Assessment of chromosomal losses and gains in hepatocellular carcinoma

被引:39
作者
Chang, J
Kim, NG
Piao, Z
Park, C
Park, KS
Paik, YK
Lee, WJ
Kim, BR
Kim, H [1 ]
机构
[1] Yonsei Univ, Coll Med, Dept Pathol, Brain Korea 21 Project Med Sci, Seoul, South Korea
[2] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea
[3] Yonsei Univ, Yonsei Proteome Res Ctr, Seoul 120749, South Korea
[4] Yonsei Univ, Coll Med, Dept Gen Surg, Seoul, South Korea
关键词
allelic imbalance; comparative genomic hybridization; hepatocellular carcinomas;
D O I
10.1016/S0304-3835(02)00083-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We examined the chromosomal changes of 22 hepatocellular carcinomas (HCCs) by comparative genomic hybridization (CGH) analysis and compared the results with that of allelotype by polymerase chain reaction based loss of heterozygosity (PCR-LOH) analysis. By CGH analysis, frequent chromosomal losses were noted in the chromosomal region of 4q (59%), 8p (77%), and 16q (50%), whereas gains were noted in 1q (86%) and 8q (77%). All of these chromosomal arms were revealed to have frequent allelic imbalances by PCR-LOH analysis, however, 9% of chromosomal aberrations were detected only by CGH analysis and 2% were detected only by PCR-LOH analysis. Our results suggest that CGH analysis gives more precise results for the screening of chromosomal aberrations in HCCs than that of PCR-LOH analysis with randomly selected microsatellite markers. (C) 2002 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:193 / 202
页数:10
相关论文
共 44 条
[1]  
Baek MJ, 2000, CANCER, V89, P60, DOI 10.1002/1097-0142(20000701)89:1<60::AID-CNCR9>3.0.CO
[2]  
2-3
[3]  
Balsara BR, 2001, GENE CHROMOSOME CANC, V30, P245, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1083>3.0.CO
[4]  
2-M
[5]  
Bentz M, 1998, GENE CHROMOSOME CANC, V21, P172, DOI 10.1002/(SICI)1098-2264(199802)21:2<172::AID-GCC14>3.3.CO
[6]  
2-T
[7]  
Boige V, 1997, CANCER RES, V57, P1986
[8]  
EDMONDSON HA, 1954, CANCER-AM CANCER SOC, V7, P462, DOI 10.1002/1097-0142(195405)7:3<462::AID-CNCR2820070308>3.0.CO
[9]  
2-E
[10]  
FUJIMORI M, 1991, CANCER RES, V51, P89